- Home
- ARE vs WST Comparison
ARE vs WST Comparison
Compare ARE & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARE
- WST
- Stock Information
- Founded
- ARE 1994
- WST 1923
- Country
- ARE United States
- WST United States
- Employees
- ARE N/A
- WST 10600
- Industry
- ARE Real Estate Investment Trusts
- WST Medical/Dental Instruments
- Sector
- ARE Real Estate
- WST Health Care
- Exchange
- ARE Nasdaq
- WST Nasdaq
- Market Cap
- ARE 13.3B
- WST 15.2B
- IPO Year
- ARE 1997
- WST N/A
- Fundamental
- Price
- ARE $77.84
- WST $201.90
- Analyst Decision
- ARE Hold
- WST Strong Buy
- Analyst Count
- ARE 9
- WST 6
- Target Price
- ARE $120.00
- WST $349.00
- AVG Volume (30 Days)
- ARE 2.0M
- WST 983.4K
- Earning Date
- ARE 04-28-2025
- WST 04-24-2025
- Dividend Yield
- ARE 6.79%
- WST 0.40%
- EPS Growth
- ARE 233.15
- WST N/A
- EPS
- ARE 1.80
- WST 6.69
- Revenue
- ARE $3,123,453,000.00
- WST $2,893,200,000.00
- Revenue This Year
- ARE N/A
- WST $0.96
- Revenue Next Year
- ARE $3.88
- WST $6.64
- P/E Ratio
- ARE $43.27
- WST $30.18
- Revenue Growth
- ARE 8.20
- WST N/A
- 52 Week Low
- ARE $71.57
- WST $187.43
- 52 Week High
- ARE $130.14
- WST $394.42
- Technical
- Relative Strength Index (RSI)
- ARE 33.90
- WST 36.70
- Support Level
- ARE $76.43
- WST $187.43
- Resistance Level
- ARE $80.46
- WST $214.62
- Average True Range (ATR)
- ARE 4.30
- WST 10.57
- MACD
- ARE -0.55
- WST 0.95
- Stochastic Oscillator
- ARE 26.94
- WST 37.92
About ARE Alexandria Real Estate Equities Inc.
Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle, Texas, and Canada. The Company is a life science real estate investment trust focused on developing, redeveloping, and operating properties that provide space for lease to tenants in the life science industry.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.